SCHEMBL260357

SCHEMBL260357

Cc1ccc(-c2ccc(CN(C)C)cc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.81
TAAR1 Q96RJ0 2/20 0.68
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52
BRD4 O60885 1/20 0.50
BRD9 Q9H8M2 1/20 0.50
PYCR1 P32322 1/20 0.48
TTK P33981 1/20 0.46
AURKB Q96GD4 1/20 0.46
INCENP Q9NQS7 1/20 0.46
CYP19A1 P11511 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
IDO1 P14902 1/20 0.42
CYP2C19 P33261 1/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
GRM2 Q14416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12374 0.93 HRH3 (0.67) HRH3TAAR1ALDH1A1TSHRBRD4
Hydrochloric Acid SCHEMBL28688142 0.90 HRH3 (0.64) HRH3TAAR1ALDH1A1TSHRPYCR1
Phosphine SCHEMBL25337730 0.90 HRH3 (0.64) HRH3TAAR1ALDH1A1TSHRBRD4
Bromide SCHEMBL3977215 0.90 HRH3 (0.64) HRH3TAAR1ALDH1A1TSHRBRD4
Bromide SCHEMBL3671914 0.90 HRH3 (0.64) HRH3TAAR1ALDH1A1TSHRBRD4
SCHEMBL12679031 0.90 HRH3 (1.00) HRH3TAAR1ALDH1A1TSHRBRD4
SCHEMBL32689849 0.82 HRH3 (0.54) HRH3TAAR1ALDH1A1TSHRPYCR1
SCHEMBL659509 0.82 HRH3 (0.82) HRH3TAAR1ALDH1A1TSHRBRD4
SCHEMBL23512760 0.81 HRH3 (0.81) HRH3TAAR1ALDH1A1TSHRBRD4
SCHEMBL5915632 0.81 TAAR1 (1.00) HRH3TAAR1ALDH1A1TSHRPYCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067440-B2 Phosphonium salts derivatives and uses thereof VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2011-11-29 US disclosed
US-20110092683-A1 PHOSPHONIUM SALTS DERIVATIVES AND USES THEREOF VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092683-A1 PHOSPHONIUM SALTS DERIVATIVES AND USES THEREOF PI4K2A, PIP4K2A, PI4K2B HRH3 3748/4885TAAR1 2924/4885ALDH1A1 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.